News

We’ve covered in the past how adding additional expirations in options markets increases overall liquidity, allowing for investors to easily customize, hedge and roll their positions across expiry ...
About This EventThe Minister of Finance of Chile visits the Nasdaq MarketSite in Times Square during ChileDay in New York.In honor of the occasion, Mr. Mario Marcel Cullell, the Minister of Finance of ...
Now, Ives says the bull case is "back on the table" for tech stocks such as Apple (NASDAQ: AAPL), Microsoft, and Palantir ...
Artificial intelligence (AI) continues to be the hottest investing topic on Wall Street, and arguably no stock has performed ...
To turn $10,000 into $1 million, Palantir will need to increase in value 100-fold. Today, the company is worth about $300 ...
About This EventPatriot National Bancorp, Inc. (Nasdaq: PNBK), the bank holding company for Stamford, Connecticut-based Patriot Bank NA, visits the Nasdaq MarketSite in Times Square.In honor of the ...
Mercedes-Benz stock (OTCMKTS: MBGAF) has had a relatively strong year so far, rising by close to 7%, outperforming the S&P 500, which has remained roughly flat year-to-date. Things have actually been ...
With so much going right for Palantir, there's only one thing eroding the stock's investment thesis: its extremely expensive valuation. It trades at a forward P/E ratio of 175 and a price-to-free-cash ...
Mirum Pharmaceuticals, Inc. today announced the appointment of Doug Sheehy, JD, as chief legal officer. Mr. Sheehy was most recently chief legal officer and secretary at Sonoma Biotherapeutics, Inc., ...
About This EventH.C. Wainwright & Co., full‐service investment bank, visits the Nasdaq MarketSite in Times Square.In honor of the occasion, the 3rd Annual BioConnect Conference, John Chambers and ...
The Nasdaq Nordic Foundation was founded in 2005 to support the financial markets through scientific research. The Foundation's mission is to promote scientific research and other initiatives ...
About This EventLigand (Nasdaq: LGND), a biopharmaceutical royalty aggregator focused on investing in highly differentiated development-stage and commercial products, visits the Nasdaq MarketSite in ...